课题基金 / 基金详情

Regulation of VEGF expression by PPAR in human lung cancer cells

Regulation of VEGF expression by PPAR in human lung cancer cells
PPAR对人肺癌细胞VEGF表达的调控
批准号:
20790562
负责人:
TANNO Sachie
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

TANNO Sachie的其他基金

相似基金

相关文献

中文摘要
翻译
糖尿病患者使用噻唑烷二酮(TZD)与肺癌风险降低特别相关。由于胶原蛋白XVIII是肺癌患者预后的最强预测因子之一,我们研究了TZD对人非小细胞肺癌(NSCLC)细胞中胶原蛋白XVIII表达的影响。本研究结果首次提示TZDs可降低NSCLC中胶原XVIII的表达,这可能有助于我们理解TZDs具有化学预防作用的机制。
英文摘要
Thiazolidinedione (TZD) use in patients with diabetes was specifically associated with reduced risk of lung cancer. Since collagen XVIII is one of the strongest predictors of outcome in patients with lung cancer, we examined the effects of TZD on expression of collagen XVIII in human non-small lung cancer (NSCLC) cells. The present results results suggest for the first time that TZDs reduced expression of collagen XVIII in NSCLC, which may help us understand the mechanism why TZDs use has chemopreventive action.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Thiazolidinediones enhance vascular endothelial growth factor expression and induce cell growth inhibition in non-small-cell lung cancer cells
噻唑烷二酮类增强非小细胞肺癌细胞中血管内皮生长因子的表达并诱导细胞生长抑制
DOI: --
发表时间: 2010
期刊: J Exp Clin Cancer Res
影响因子: --
作者: [Yoshizaki T, Motomura W, Tanno S, Kumei S, Yoshizaki Y, Tanno S, Okumura T]
通讯作者: Okumura T
Monitoring of Emerging Resistance of Lung Cancer using Liquid Biopsy
  • 批准号:
    15K09239
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.08万
  • 财政年份:
    2015
  • 负责人:
    TANNO Sachie
  • 依托单位:
海外基金